Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
OMCL's Cash to Debt is ranked higher than
99% of the 2645 Companies
in the Global Health Information Services industry.

( Industry Median: 5.50 vs. OMCL: No Debt )
OMCL' s 10-Year Cash to Debt Range
Min: 1.42   Max: No Debt
Current: No Debt

Equity to Asset 0.70
OMCL's Equity to Asset is ranked higher than
76% of the 2564 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. OMCL: 0.70 )
OMCL' s 10-Year Equity to Asset Range
Min: -0.57   Max: 0.78
Current: 0.7

-0.57
0.78
Interest Coverage No Debt
OMCL's Interest Coverage is ranked higher than
83% of the 1630 Companies
in the Global Health Information Services industry.

( Industry Median: 5615.56 vs. OMCL: No Debt )
OMCL' s 10-Year Interest Coverage Range
Min: 44.6   Max: 9999.99
Current: No Debt

44.6
9999.99
F-Score: 7
Z-Score: 6.15
M-Score: -2.47
WACC vs ROIC
9.24%
12.06%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 11.25
OMCL's Operating margin (%) is ranked higher than
82% of the 2614 Companies
in the Global Health Information Services industry.

( Industry Median: 5.77 vs. OMCL: 11.25 )
OMCL' s 10-Year Operating margin (%) Range
Min: -29   Max: 11.25
Current: 11.25

-29
11.25
Net-margin (%) 6.92
OMCL's Net-margin (%) is ranked higher than
78% of the 2614 Companies
in the Global Health Information Services industry.

( Industry Median: 3.77 vs. OMCL: 6.92 )
OMCL' s 10-Year Net-margin (%) Range
Min: -30.86   Max: 20.32
Current: 6.92

-30.86
20.32
ROE (%) 8.20
OMCL's ROE (%) is ranked higher than
73% of the 2551 Companies
in the Global Health Information Services industry.

( Industry Median: 6.64 vs. OMCL: 8.20 )
OMCL' s 10-Year ROE (%) Range
Min: -28.06   Max: 28.62
Current: 8.2

-28.06
28.62
ROA (%) 5.76
OMCL's ROA (%) is ranked higher than
77% of the 2658 Companies
in the Global Health Information Services industry.

( Industry Median: 3.43 vs. OMCL: 5.76 )
OMCL' s 10-Year ROA (%) Range
Min: -7.04   Max: 17.93
Current: 5.76

-7.04
17.93
ROC (Joel Greenblatt) (%) 59.94
OMCL's ROC (Joel Greenblatt) (%) is ranked higher than
79% of the 2628 Companies
in the Global Health Information Services industry.

( Industry Median: 31.00 vs. OMCL: 59.94 )
OMCL' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -113.41   Max: 141.68
Current: 59.94

-113.41
141.68
Revenue Growth (3Y)(%) 18.70
OMCL's Revenue Growth (3Y)(%) is ranked higher than
89% of the 2058 Companies
in the Global Health Information Services industry.

( Industry Median: 5.50 vs. OMCL: 18.70 )
OMCL' s 10-Year Revenue Growth (3Y)(%) Range
Min: -53.3   Max: 18.7
Current: 18.7

-53.3
18.7
EBITDA Growth (3Y)(%) 39.10
OMCL's EBITDA Growth (3Y)(%) is ranked higher than
94% of the 1682 Companies
in the Global Health Information Services industry.

( Industry Median: 6.20 vs. OMCL: 39.10 )
OMCL' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -14.1   Max: 124.1
Current: 39.1

-14.1
124.1
EPS Growth (3Y)(%) 40.40
OMCL's EPS Growth (3Y)(%) is ranked higher than
91% of the 1537 Companies
in the Global Health Information Services industry.

( Industry Median: 6.70 vs. OMCL: 40.40 )
OMCL' s 10-Year EPS Growth (3Y)(%) Range
Min: -69.7   Max: 260.9
Current: 40.4

-69.7
260.9
» OMCL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

OMCL Guru Trades in Q2 2014

Jim Simons 103,943 sh (New)
Ken Fisher 410,000 sh (New)
Paul Tudor Jones 16,552 sh (+14.94%)
Joel Greenblatt 43,389 sh (-5.57%)
» More
Q3 2014

OMCL Guru Trades in Q3 2014

Paul Tudor Jones 24,905 sh (+50.47%)
Ken Fisher 492,478 sh (+20.12%)
Jim Simons 90,443 sh (-12.99%)
Joel Greenblatt 35,084 sh (-19.14%)
» More
Q4 2014

OMCL Guru Trades in Q4 2014

Ken Fisher 559,000 sh (+13.51%)
Joel Greenblatt Sold Out
Jim Simons 90,343 sh (-0.11%)
Paul Tudor Jones 9,979 sh (-59.93%)
» More
Q1 2015

OMCL Guru Trades in Q1 2015

Ken Fisher 554,250 sh (-0.85%)
» More
» Details

Insider Trades

Latest Guru Trades with OMCL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 42.30
OMCL's P/E(ttm) is ranked higher than
72% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 86.80 vs. OMCL: 42.30 )
OMCL' s 10-Year P/E(ttm) Range
Min: 8.94   Max: 795.88
Current: 42.3

8.94
795.88
Forward P/E 26.25
OMCL's Forward P/E is ranked higher than
79% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. OMCL: 26.25 )
N/A
PE(NRI) 42.90
OMCL's PE(NRI) is ranked higher than
75% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 87.80 vs. OMCL: 42.90 )
OMCL' s 10-Year PE(NRI) Range
Min: 8.97   Max: 676.5
Current: 42.9

8.97
676.5
P/B 3.20
OMCL's P/B is ranked higher than
65% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 3.70 vs. OMCL: 3.20 )
OMCL' s 10-Year P/B Range
Min: 0.96   Max: 8.11
Current: 3.2

0.96
8.11
P/S 2.92
OMCL's P/S is ranked higher than
55% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 2.72 vs. OMCL: 2.92 )
OMCL' s 10-Year P/S Range
Min: 0.94   Max: 4.69
Current: 2.92

0.94
4.69
PFCF 30.10
OMCL's PFCF is ranked higher than
76% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 276.80 vs. OMCL: 30.10 )
OMCL' s 10-Year PFCF Range
Min: 8.57   Max: 730
Current: 30.1

8.57
730
POCF 20.10
OMCL's POCF is ranked higher than
77% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 33.50 vs. OMCL: 20.10 )
OMCL' s 10-Year POCF Range
Min: 7.42   Max: 1010
Current: 20.1

7.42
1010
EV-to-EBIT 23.41
OMCL's EV-to-EBIT is ranked higher than
77% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 45.39 vs. OMCL: 23.41 )
OMCL' s 10-Year EV-to-EBIT Range
Min: -1140.1   Max: 424.9
Current: 23.41

-1140.1
424.9
PEG 1.02
OMCL's PEG is ranked higher than
97% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. OMCL: 1.02 )
OMCL' s 10-Year PEG Range
Min: 0.5   Max: 42.93
Current: 1.02

0.5
42.93
Shiller P/E 85.10
OMCL's Shiller P/E is ranked higher than
81% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. OMCL: 85.10 )
OMCL' s 10-Year Shiller P/E Range
Min: 15.61   Max: 299.13
Current: 85.1

15.61
299.13
Current Ratio 2.52
OMCL's Current Ratio is ranked higher than
75% of the 2621 Companies
in the Global Health Information Services industry.

( Industry Median: 1.92 vs. OMCL: 2.52 )
OMCL' s 10-Year Current Ratio Range
Min: 0.73   Max: 4.79
Current: 2.52

0.73
4.79
Quick Ratio 2.24
OMCL's Quick Ratio is ranked higher than
73% of the 2621 Companies
in the Global Health Information Services industry.

( Industry Median: 1.82 vs. OMCL: 2.24 )
OMCL' s 10-Year Quick Ratio Range
Min: 0.52   Max: 4.48
Current: 2.24

0.52
4.48
Days Inventory 55.49
OMCL's Days Inventory is ranked higher than
75% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 369.00 vs. OMCL: 55.49 )
OMCL' s 10-Year Days Inventory Range
Min: 35.43   Max: 128.75
Current: 55.49

35.43
128.75
Days Sales Outstanding 68.52
OMCL's Days Sales Outstanding is ranked higher than
77% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 87.85 vs. OMCL: 68.52 )
OMCL' s 10-Year Days Sales Outstanding Range
Min: 44.3   Max: 88.48
Current: 68.52

44.3
88.48

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 37.40
OMCL's Price/Net Current Asset Value is ranked higher than
69% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. OMCL: 37.40 )
OMCL' s 10-Year Price/Net Current Asset Value Range
Min: 2.19   Max: 27.81
Current: 37.4

2.19
27.81
Price/Tangible Book 7.70
OMCL's Price/Tangible Book is ranked higher than
62% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 9.30 vs. OMCL: 7.70 )
OMCL' s 10-Year Price/Tangible Book Range
Min: 1.2   Max: 16.59
Current: 7.7

1.2
16.59
Price/DCF (Projected) 1.90
OMCL's Price/DCF (Projected) is ranked higher than
82% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. OMCL: 1.90 )
OMCL' s 10-Year Price/DCF (Projected) Range
Min: 1.16   Max: 8.67
Current: 1.9

1.16
8.67
Price/Median PS Value 1.30
OMCL's Price/Median PS Value is ranked higher than
65% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 1.30 vs. OMCL: 1.30 )
OMCL' s 10-Year Price/Median PS Value Range
Min: 0.25   Max: 1.93
Current: 1.3

0.25
1.93
Price/Peter Lynch Fair Value 1.70
OMCL's Price/Peter Lynch Fair Value is ranked higher than
94% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. OMCL: 1.70 )
OMCL' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.32   Max: 23.38
Current: 1.7

1.32
23.38
Price/Graham Number 3.70
OMCL's Price/Graham Number is ranked higher than
75% of the 2972 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. OMCL: 3.70 )
OMCL' s 10-Year Price/Graham Number Range
Min: 1.59   Max: 8.12
Current: 3.7

1.59
8.12
Earnings Yield (Greenblatt) 4.40
OMCL's Earnings Yield (Greenblatt) is ranked higher than
72% of the 2593 Companies
in the Global Health Information Services industry.

( Industry Median: 3.30 vs. OMCL: 4.40 )
OMCL' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 15.9
Current: 4.4

0.2
15.9
Forward Rate of Return (Yacktman) 42.33
OMCL's Forward Rate of Return (Yacktman) is ranked higher than
96% of the 1076 Companies
in the Global Health Information Services industry.

( Industry Median: 11.78 vs. OMCL: 42.33 )
OMCL' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5.2   Max: 45
Current: 42.33

-5.2
45

Business Description

Industry: Application Software » Health Information Services
Compare:CERN, CTRX, ATHN, MDRX, AH » details
Traded in other countries:OC9.Germany,
Omnicell Inc is a Delaware corporation incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. The Company is a provider of automation and business information solutions enabling healthcare systems to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. The Company's automation, analytics and medication adherence solutions in hospitals and longer-term care environments are designed to enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies and are intended to enhance patient safety, reduce medication errors, reduce operating costs, improve workflow, and increase operational efficiency. Approximately 6,500 hospitals, institutional pharmacies, and retail pharmacies use Company's products. The Company is organized into two operating business segments: Acute Care, which includes products and services sold to hospital customers, and Non-Acute Care, which includes products and services sold to customers outside of the hospital setting. In acute care facilities, its solutions use software‑based medication control and tracking algorithms that interact with hardware security features, resulting in a system that provides both the pharmacist and the nurse real-time safety controls. It also provides medication bar code verification at every step of the medication administration process, from entry to the hospital through the administration of the medication to a patient. Its systems enables customers to reduce or eliminate inefficiencies such as manual tracking and reconciliations, nursing time spent in obtaining medications and in performing inventory control and extraneous process steps. Similar to its medication solutions, Company's medical and surgical supply systems provide hospitals control over consumable supplies critical to providing quality healthcare. Its solutions provide inventory control software that is designed to ensure critical supplies are always stocked in the right locations. It also offers analytics and reporting software for pharmacists and material managers to more easily manage inventory flow, tracking and optimization. The Non-Acute Care segment represents products sold outside the hospital setting and includes medication adherence products sold under the brand name of MTS, and dispensing systems sold under the Omnicell brand. The MTS products consist of proprietary medication packaging systems and related products for use by institutional pharmacies servicing long-term care, and correctional facilities or retail pharmacies serving patients in their local communities. These systems use consumable medication punch cards and specialized machines that allow the pharmacies to automatically or semi-automatically assemble, fill and seal drugs into medication punch cards representing a w
» More Articles for OMCL

Headlines

Articles On GuruFocus.com
Ken Fisher's Top 5 New Portfolio Stocks Jul 27 2014 
comment on OMCL May 26 2013 
Omnicell Inc. (OMCL) V.P., Finance & CFO Robin Gene Seim sells 1,250 Shares Feb 03 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,997 Shares Jan 24 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,997 Shares Jan 12 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 937 Shares Jan 05 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 3,351 Shares Dec 22 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 1,500 Shares Dec 03 2010 
Omnicell Inc. (OMCL) V.P., Finance & CFO Robin Gene Seim sells 4,265 Shares Nov 30 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,372 Shares Oct 22 2010 

More From Other Websites
OMNICELL, INC Files SEC form 8-K, Change in Directors or Principal Officers May 01 2015
Omnicell tops Street 1Q forecasts Apr 30 2015
Omnicell tops Street 1Q forecasts Apr 30 2015
Omnicell Announces First Quarter 2015 Results Apr 30 2015
4:13 pm Omnicell beats by $0.06, beats on revs Apr 30 2015
OMNICELL, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 30 2015
Omnicell Announces First Quarter 2015 Results Apr 30 2015
Omnicell, Inc. Increases U.K. Commitment and Presence with Acquisition of Longtime Partner Avantec... Apr 30 2015
Omnicell, Inc. Increases U.K. Commitment and Presence with Acquisition of Longtime Partner Avantec... Apr 30 2015
Q1 2015 Omnicell Inc Earnings Release - After Market Close Apr 30 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Omnicell, Inc. of Pendency of... Apr 29 2015
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Omnicell, Inc. - OMCL Apr 29 2015
10-K for Omnicell, Inc. Apr 28 2015
Erlanger Health System to Install Omnicell Solutions for Medication Management Apr 27 2015
Erlanger Health System to Install Omnicell Solutions for Medication Management Apr 27 2015
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving... Apr 23 2015
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Apr 23 2015
Omnicell to Release First Quarter 2015 Earnings Results on April 30th Apr 23 2015
Omnicell to Release First Quarter 2015 Earnings Results on April 30th Apr 23 2015
Omnicell Regains Nasdaq Listing Compliance Apr 23 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK